Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 4
1987 3
1988 4
1989 6
1990 8
1991 7
1992 12
1993 8
1994 10
1995 12
1996 20
1997 21
1998 25
1999 41
2000 35
2001 36
2002 47
2003 51
2004 73
2005 90
2006 108
2007 110
2008 161
2009 179
2010 228
2011 286
2012 321
2013 372
2014 414
2015 524
2016 544
2017 598
2018 668
2019 774
2020 908
2021 1171
2022 1368
2023 1360
2024 1561
2025 1841
2026 99

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,618 results

Results by year

Filters applied: . Clear all
Page 1
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.
Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Li W, Lu D, Hu M, Maxwell Wang Z, Li B, Xia M, Lu S. Chen Z, et al. Among authors: ji y. Lancet. 2025 Nov 1;406(10515):2078-2088. doi: 10.1016/S0140-6736(25)01848-3. Epub 2025 Oct 19. Lancet. 2025. PMID: 41125109 Clinical Trial.
The genetic architecture of brainstem structures.
Xue H, Fu J, Geng Z, Cheng J, Wang M, Zhang L, Cui G, Yu Y, Liao W, Zhang H, Gao B, Xu X, Han T, Yao Z, Zhang Q, Qin W, Liu F, Liang M, Wang S, Xu Q, Xu J, Wang C, Liu N, Ji Y, Zhang P, Li W, Wei W, Shi D, Lui S, Yan Z, Chen F, Zhang J, Shen W, Miao Y, Wang D, Gao JH, Yang Y, Xu K, Xian J, Zhang B, Zhang X, Zuo XN, Li MJ, Ye Z, Qiu S, Zhu W, Yu C; CHIMGEN Consortium. Xue H, et al. Among authors: ji y. Nat Commun. 2025 Dec 10. doi: 10.1038/s41467-025-67221-6. Online ahead of print. Nat Commun. 2025. PMID: 41372214 Free article.
Pharmacogenomic Testing.
Ji Y, Brunk L, Bove B, Danyal K, Langman LJ, Mot N, Mroz P, Natowicz M, Reddi H, Shirts B, Smock K, Wool GD, Zhang BM, Moyer AM. Ji Y, et al. Arch Pathol Lab Med. 2025 Nov 22. doi: 10.5858/arpa.2025-0179-CP. Online ahead of print. Arch Pathol Lab Med. 2025. PMID: 41270809 Free article.
S-nitrosoglutathione reductase as a therapeutic target for diabetic vascular complications in rodent models.
Zhao S, Song T, Tang X, Fan C, Yang Y, Zhang Z, Xia Y, Zhang Y, Cao J, Wang Z, Shi Z, Tang X, Wang D, Yin G, Zhang S, Gao Y, Chen H, Wang L, Chen F, Wang H, Yu B, Cao Y, Sun K, Liu X, Wang X, Yan C, Han Y, Han Y, Xie L, Ji Y. Zhao S, et al. Among authors: ji y. Sci Transl Med. 2025 Oct;17(818):eadn9216. doi: 10.1126/scitranslmed.adn9216. Epub 2025 Oct 1. Sci Transl Med. 2025. PMID: 41032622
Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade.
Wu MM, Yang YC, Hu ZQ, Chang JY, Xiao H, Miao C, Zhang BW, He ZX, Zhu D, Duan YR, Wang S, Liu JY, Guo ZP, Sun Y, Liu DY, Yu M, Zhang Y, Mao JJ, Jiang S, Zhang BK, Mei Z, Gao J, Liang C, Wang QS, Yu CJ, Zhao D, Yan CH, Li Y, Pan ZW, Chen Z, Xu DQ, Liu T, Ji Y, Zhang ZR. Wu MM, et al. Among authors: ji y. Cell Metab. 2026 Jan 6;38(1):208-227.e12. doi: 10.1016/j.cmet.2025.11.009. Epub 2025 Dec 10. Cell Metab. 2026. PMID: 41380676
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial.
Wang Z, Fan J, Zhou S, Sun Y, Liang F, Ji Y, Gu F, Li T, Peng L, Peng T, Huang X, Ding Z, Bai D, Xiang B, Tan G, Wen T, Zeng Y, Han F, Zhang Y, Wu S, Zhao H, Chen Y, Shi G, Hou Z, Sun Y, Zhu W, Zhou J. Wang Z, et al. Among authors: ji y. Lancet. 2025 Nov 1;406(10515):2089-2099. doi: 10.1016/S0140-6736(25)01720-9. Epub 2025 Oct 19. Lancet. 2025. PMID: 41125112 Clinical Trial.
CD177+ neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regeneration.
Yan J, Huang A, Zhang S, Yao N, Huang J, Jiang Z, Wang J, Chen F, Yu Q, Cheng J, Zhang S, Li T, Gao R, Miao R, Luo R, Zhou S, Ji Y, Wang Z, Gao D, Ding Z, Tang Z, Fan J, Esteban MA, Schlitt HJ, Yang X, Zhou J. Yan J, et al. Among authors: ji y. Gut. 2025 Dec 25:gutjnl-2025-336300. doi: 10.1136/gutjnl-2025-336300. Online ahead of print. Gut. 2025. PMID: 41390175 Free article.
12,618 results
You have reached the last available page of results. Please see the User Guide for more information.